Acellular Arterial Tissue Matrix for Tendon Repair

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The healing of tendons and ligaments often results in severe scarring and adhesion to surrounding tissues, limiting range of motion and altering material properties, as existing treatments fail to effectively prevent scar formation and adhesion during the healing process.

Innovation Solution

A device comprising an acellular arterial tissue matrix, derived from an arterial section with intact basement membrane, is used to protect and treat damaged tendons or ligaments by creating a protective environment that minimizes scar formation and adhesion, facilitating healing by maintaining growth factors and cytokines.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional healing methods are used for tendon and ligament repair, then the tissue will heal, but severe scarring and adhesion to surrounding tissues will occur, limiting range of motion and altering material properties

Engineering Contradiction:
Improvehealing effectivenessVSAvoidscar formation and adhesion
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

An acellular arterial tissue matrix is introduced as an intermediary barrier between the damaged tendon/ligament and surrounding tissues. This matrix serves as a temporary scaffold that facilitates healing while preventing direct contact between the healing tissue and surrounding fibrous tissues, thereby eliminating adhesion formation. The matrix is derived from arterial tissue and processed to remove cellular components while preserving the extracellular matrix structure.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The acellular arterial tissue matrix functions as a flexible thin film or shell that wraps around or is placed over the damaged tendon or ligament. This flexible barrier provides physical protection during healing while allowing for tissue movement and expansion. The matrix maintains its structural integrity while accommodating the dynamic nature of tendon and ligament healing processes.

Inventive Principle:
Principle #30Flexible shells and thin films

2Reliability

If the tendon or ligament is left exposed during healing, then the natural healing process can proceed, but growth factors and cytokines are lost, and scarring increases

Engineering Contradiction:
Improvehealing processVSAvoidgrowth factors and cytokines
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The acellular arterial tissue matrix creates a protected, controlled environment around the damaged tendon or ligament. This protective barrier minimizes exposure to external factors that could cause harm while maintaining a conducive environment for healing. The matrix preserves the natural biochemical environment by preventing loss of growth factors and cytokines, allowing these essential substances to remain concentrated at the injury site to promote regeneration.

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

3Reliability

If scar formation occurs during healing, then the tissue will heal, but the range of motion is limited and material properties are altered

Engineering Contradiction:
Improvetissue healingVSAvoidrange of motion
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The acellular matrix acts as a mediator that separates the healing tendon or ligament from surrounding tissues that would otherwise cause adhesion. By preventing direct contact between the healing tissue and surrounding fibrous tissues, the matrix eliminates the formation of restrictive scar adhesions while still allowing controlled tissue regeneration. This results in healed tissue that maintains its natural range of motion and mechanical properties.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS10667900B2Device for tendon and ligament treatment
Publication Date: 2020.06.02 LIFECELL CORP
  • US10667900B2 patent drawing
  • US10667900B2 patent drawing
  • US10667900B2 patent drawing

AI summary

Devices and methods for treating defects in connective tissue are provided along with methods for making such devices. The devices can include acellular arterial tissue matrices that facilitate regrowth of the damaged tissue.